This doubles team is hitting all the right shots! Serena Williams had social media swooning on Monday when she posted photos of herself “sharing her passion” for tennis with her 2-year-old daughter, Adira.
In photos…

This doubles team is hitting all the right shots! Serena Williams had social media swooning on Monday when she posted photos of herself “sharing her passion” for tennis with her 2-year-old daughter, Adira.
In photos…

Ever wondered if Thermo Fisher Scientific’s stock is truly worth its current price? Let’s dive into what those numbers may be telling us.
The share price has climbed an impressive 14.4% over the past year, with a 12.2% gain so far in 2024. This signals growing investor confidence and possible changes in how the market perceives the company’s risks and rewards.
Recently, Thermo Fisher has been in the spotlight after expanding partnerships with major pharmaceutical players and making acquisitions aimed at boosting its life sciences capabilities. These moves have not only captured the industry’s attention but may also have played a role in the recent share price uplift.
According to Simply Wall St’s value checks, Thermo Fisher Scientific scores a 3 out of 6 on the undervalued scale. This gives us a jumping-off point for examining how the market values this stock. Stay tuned, as we will unpack commonly used valuation approaches and reveal what might be an even smarter way to think about valuation later in the article.
Thermo Fisher Scientific delivered 14.4% returns over the last year. See how this stacks up to the rest of the Life Sciences industry.
The Discounted Cash Flow (DCF) model estimates a company’s true value by projecting its future cash flows and then discounting those amounts back to today’s dollars. This approach aims to capture the intrinsic worth of Thermo Fisher Scientific based solely on its ability to generate cash in the years ahead.
Currently, Thermo Fisher Scientific reports a Free Cash Flow (FCF) of $6.1 Billion. Analyst forecasts show FCF rising steadily each year, reaching a projected $11.3 Billion by 2029. While these analyst estimates extend for about five years, forecasts beyond that are extrapolated to provide a longer-term picture of cash generation potential.
According to the DCF analysis, Thermo Fisher Scientific’s intrinsic value stands at $605.35 per share. Based on recent share prices, the stock is trading at about a 3.2% discount to this estimated fair value. This suggests the market price and the underlying value are quite closely aligned.
Result: ABOUT RIGHT
Thermo Fisher Scientific is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment’s notice. Track the value in your watchlist or portfolio and be alerted on when to act.
Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Thermo Fisher Scientific.
For profitable companies like Thermo Fisher Scientific, the Price-to-Earnings (PE) ratio is one of the most widely used methods to gauge valuation. This metric compares a company’s share price to its per-share earnings, making it particularly useful for investors trying to determine if a stock is expensive or attractively priced relative to profits.

It’s been more than two months since the New England Patriots lost a football game. After falling to the Pittsburgh Steelers in Week 3, the Patriots have rattled off nine consecutive wins, the latest coming Sunday with a victory over the…

In the earliest text written in Marathi, a language of millions in western and central India, a 13th-century religious figure named Cakradhara points to an acacia tree as a symbol of the cycle of death and reincarnation.
It’s unlikely he…

Oscar-winning filmmaker Richard Trank has been making documentaries about Israel for decades. Today, he finally lives here.
“I wish I had made this decision earlier,” Trank told The Times of Israel about his aliyah to Israel last month,…

Director Joachim Trier’s “Sentimental Value” is a searing portrait of a family set in Oslo. The film marks the third collaboration between Trier and actress Renate Reinsve, following their 2021…

AUD/USD finished lower last week at 0.6455, down 1.22%. The decline came against a backdrop of broad-based US dollar, with the US Dollar Index (DXY) hitting its highest level since late May.
The big dollar’s rally was fuelled by a combination of risk-aversion flows, disappointing economic data out of Europe and the United Kingdom, and a sharp sell-off in the Japanese yen ahead of the sizeable fiscal stimulus package formally approved on Friday. Reinforcing the move, several regional Federal Reserve (Fed) presidents sounded hawkish, expressing concerns about additional rate cuts due to lingering inflation risks.
However, that hawkish tilt began to reverse on Friday when New York Fed President John Williams indicated he still saw scope to lower rates further ‘in the near term’. The dovish message gained further traction overnight when Fed Governor Christopher Waller noted that the recent softening in the labour market made a December rate cut quite plausible.
The probability of a 25 basis point (bp) cut at the 10 December Federal Open Market Committee (FOMC) meeting has surged from around 30% in the middle of last week to approximately 80% now. This rapid repricing of Fed expectations has provided immediate support to AUD/USD and other risk-sensitive assets, allowing the pair to stabilise into the Friday close and extend a modest recovery into the early part of this week.
Whether a stronger bounce can follow will depend on several key drivers:
Date: Wednesday, 26 November at 11.30am AEDT
Australia is transitioning from a quarterly to a full monthly consumer price index (CPI) as its primary measure of headline inflation – a change that will start this Wednesday. This alignment with other Group of Twenty (G20) countries will facilitate easier comparisons of inflation trends with other advanced economies.
There is ongoing debate about whether the new monthly data should be compared with the previous quarterly figures or the last monthly CPI indicator, and it will take time before the Reserve Bank of Australia (RBA) can fully rely on the monthly CPI for a complete and accurate assessment of inflation pressures compared to the more consistent quarterly data.
Although neither option provides a perfect comparison, we have opted to go with the recently released third quarter (Q3) numbers for clarity. In Q3 2025, headline CPI rose 1.3% quarter-on-quarter (QoQ), bringing the annual rate to 3.2% year-on-year (YoY), up from 2.1% previously. The trimmed mean increased 1.0% QoQ, lifting its annual rate to 3.0% YoY from 2.7%, marking the first increase since December 2022.
Following this, expectations are for a monthly increase of 3.6% over the year and for a reading of 2.9% for the trimmed mean. The Australian interest rate market starts the day pricing in 2 bp of easing for the RBA’s December meeting, with roughly 13 bp of cuts anticipated by May 2026.